Skip to content
    Font Size
    A
    A
    A

    Drug for Enlarged Prostate May Slow Cancer Growth

    Could Avodart Be an Alternative to Surgery, Radiation for Low-Risk Prostate Cancer?
    By
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Jan. 23, 2012 -- A drug widely prescribed to treat men with enlarged prostates may also slow the growth of early prostate cancers, according to a new study.

    Researchers say the drug Avodart (dutasteride) may reduce the need for aggressive treatments in men who have a very low risk of dying from their disease.

    But there are also concerns that the drug and others in the same class may have no effect on more deadly cancers or may actually fuel their growth, leading several experts to conclude that more study is needed before they can be recommended as a treatment of prostate cancer.

    “These drugs are not without side effects,” says Durado Brooks, MD, MPH, who is director of prostate and colorectal cancers for the American Cancer Society. “They do seem to decrease the growth of low-grade cancers, but questions remain about whether they have much activity against high-grade disease.”

    Most Prostate Cancers Aren’t Deadly

    As many as 1 in 5 men in the United States will be diagnosed with prostate cancer at some time in their lives, but most have low-risk cancers that will never cause them harm.

    Withholding treatment while closely monitoring the cancer, known as watchful waiting or active surveillance, is increasingly recommended as an alternative to surgery or radiation for men with low-risk cancers.

    The strategy is now common in many parts of the world, but most American men still opt for active treatment.

    “Nine out of 10 men with low-risk disease in the U.S. are still getting treatment, either because they aren’t offered active surveillance or because they rejected it,” Brooks says. “Americans are action oriented, and the idea of not treating a known cancer goes against the U.S. psyche.”

    Since surgery and radiation involve a risk of life-altering side effects, including erectile dysfunction and incontinence, different treatment approaches are needed for men with low-risk disease, says Neil E. Fleshner, MD, MPH, of Toronto’s Princess Margaret Hospital.

    Fleshner and colleagues recruited slightly more than 300 men with low-risk prostate cancers to assess the impact of Avodart on cancer progression.

    Today on WebMD

    man with doctor
    Symptoms, risks, treatments
    man coughing
    Men shouldn’t ignore
     
    prostate cancer cells
    What does this diagnosis mean?
    doctor and male patient
    Is it worth it?
     
    cancer fighting foods
    SLIDESHOW
    15 Cancer Symptoms Men Ignore
    FEATURE
     
    Prostate Enlarged
    VIDEO
    Picture Of The Prostate
    ANATOMY
     
    Prostate Cancer Quiz
    QUIZ
    screening tests for men
    SLIDESHOW
     
    Prostate Cancer Symptoms
    VIDEO
    Vitamin D
    SLIDESHOW